ReShape Lifesciences Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
ReShape Lifesciences Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2015 to Q3 2024.
  • ReShape Lifesciences Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.58M, a 55.3% increase year-over-year.
  • ReShape Lifesciences Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$7.07M, a 73% increase year-over-year.
  • ReShape Lifesciences Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$11.4M, a 75.4% increase from 2022.
  • ReShape Lifesciences Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$46.2M, a 26.8% increase from 2021.
  • ReShape Lifesciences Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$63.1M, a 192% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$7.07M -$1.58M +$1.95M +55.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$9.02M -$1.6M +$1.9M +54.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$10.9M -$2.19M +$469K +17.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$11.4M -$1.7M +$14.8M +89.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$26.2M -$3.53M +$8.65M +71% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$34.8M -$3.49M +$5.95M +63% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$40.8M -$2.66M +$5.45M +67.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$46.2M -$16.5M +$20.8M +55.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$67M -$12.2M +$4.95M +28.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$71.9M -$9.44M -$5.56M -143% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$66.4M -$8.12M -$3.24M -66.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$63.1M -$37.2M -$29.7M -391% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 -$33.5M -$17.1M -$12M -231% Jul 1, 2021 Sep 30, 2021 10-K 2023-04-17
Q2 2021 -$21.5M -$3.89M -$285K -7.91% Apr 1, 2021 Jun 30, 2021 10-K 2023-04-17
Q1 2021 -$21.2M -$4.87M +$387K +7.36% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 -$21.6M -$7.59M -$2.67M -54.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-08
Q3 2020 -$19M -$5.18M -$1.47M -39.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$17.5M -$3.6M +$3.16M +46.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$20.6M -$5.26M +$3.03M +36.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$23.7M -$4.91M +$3.84M +43.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 -$27.5M -$3.71M +$3.04M +45.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$30.6M -$6.77M +$2.99M +30.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-06
Q1 2019 -$33.5M -$8.29M +$3.84M +31.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-06
Q4 2018 -$37.4M -$8.76M +$1.36M +13.5% Oct 1, 2018 Dec 31, 2018 10-K 2019-02-22
Q3 2018 -$38.7M -$6.75M +$2.43M +26.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$41.2M -$9.75M -$2.02M -26.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-08
Q1 2018 -$39.1M -$12.1M -$4.38M -56.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-08
Q4 2017 -$34.8M -$10.1M -$2.63M -35% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-22
Q3 2017 -$32.1M -$9.17M -$3.91M -74.3% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-22
Q2 2017 -$28.2M -$7.73M -$3.6M -87.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-22
Q1 2017 -$24.6M -$7.75M -$4.16M -116% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-22
Q4 2016 -$20.5M -$7.5M -$2.66M -54.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-05
Q3 2016 -$17.8M -$5.26M -$1.7M -47.7% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-05
Q2 2016 -$16.1M -$4.13M +$893K +17.8% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-05
Q1 2016 -$17M -$3.58M -$1.45M -67.9% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-05
Q4 2015 -$15.6M -$4.84M Oct 1, 2015 Dec 31, 2015 10-K 2017-02-23
Q3 2015 -$3.56M Jul 1, 2015 Sep 30, 2015 10-K 2017-02-23
Q2 2015 -$5.02M Apr 1, 2015 Jun 30, 2015 10-K 2017-02-23
Q1 2015 -$2.13M Jan 1, 2015 Mar 31, 2015 10-K 2017-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.